Article
Identification and Validation of a Novel Prognostic Model Based on Platinum Resistance-Related Genes in Bladder Cancer
2022-06-01
Abstract excerpt
<h4>Background: </h4> Bladder cancer (BC) is a heterogeneous disease with high recurrence rate. The depth of response to platinum-based chemotherapeutic agents in urothelial neoplasm tissues varies greatly. Biomarkers that have practical value in prognosis stratification and early determination of therapeutic effect are increasingly needed. Our study aimed to select a set of BC-related genes involved in both plati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 49a256f5-e280-5097-b714-692db07112ca
- DOI
- 10.21203/rs.3.rs-1680830/v1
